Pretest Immunology
Immunology
Allergy & Food intolerance
ELISA and IFA tests simultaneously on MAGO 4 Wide range of ELISA, IFA and ImmunoBlot tests MAGO 4 pre-programmed test procedures Quantitative detection of total IgE...
Product detail »Antiphospholipid syndrome
Antiphospholipid syndrome automation with MAGO 4 Open immunoanalytical system Automated processing of ELISA and IFA tests simultaneouly in one batch 104 samples, barcodes, disposable tips...
- 1 The Immunology of Chronic Lymphocytic Leukemia Megan S. Lim MD PhD Professor Director of Division of Hematopathology (HUP/CHOP) Director of Lymphoma.
- Used Immunology Analyzer. Tosoh AIA-360 Immunoassay Analyzer. Throughput of 36 Tests per hour. Quick calibration curve reporting.
Autoimmune disease
More Anatomy Lessons: Anatomy video Anatomy vagin Anatomy penis Anatomy prof students Anatomy videos medical.
ELISA and IFA tests - Simultaneously on MAGO 4 Wide range of ELISA, IFA and immunoblot tests MAGO 4 pre-programmed assay procedures Diagnostics of connective...
Common Immunology Tests
Product detail »ELAN 30s
Fully Automated ELISA Microstrip Processor With the fully automated ELAN 30s, you have all the automation you need to achieve greater workflow efficiency. Complete...
Product detail »Infection diseases
Infection diseases diagnostics automation with MAGO 4 Wide range of ELISA tests for infection disease diagnostics Similar test protocols for individual product groups MAGO 4...
Product detail »LisaScan EM
Automated ELISA microplate reader The LisaScan EM offers objective and standard reading of ELISA microplates with interpretation. Product Features: Memory for 100 programs...
Product detail »LisaWash
Immunology Test Questions
Erba Lisa Wash is a microplate washer which enables to program up to 64 different wash protocols. Product Application: ELISA microplates washing Touch...
Product detail »- Infographics and risk factors associated with seroprevalence of SARS-CoV-2 antibodies in HCWs1 of 6
- Professor Ravi Gupta named as one of Time Magazine’s 100 Most Influential People of the Year2 of 6
- Professor Gordon Dougan receives Albert B Sabin Gold Medal Award for work in vaccinology3 of 6
- New prognostic test could enable personalised treatment of inflammatory bowel disease5 of 6
The Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID) was established by the Department of Medicine to support both fundamental and translational research on human disease.
Immunology Test Results
It houses up to 250 scientists working within 25 research groups. Our work focusses on understanding the pathogenesis and improving the management of immune-related disorders and transforming our understanding of how the infectious agents interact with humans.
CITIID transforms immunity and infection research in Cambridge by providing researchers with advanced facilities that are in close proximity and enable them to optimise their work on human immune, inflammatory and infectious diseases. By bringing together its clinical capabilities and key industry partners, CITIID is also well-placed to drive therapeutic breakthroughs, improve patient outcomes and advance population health both in the UK and abroad.
- Single-cell transcriptomics and proteomics profiling of COVID19 samples reveals immune and HSPC changes that are differentially associated with disease severity-
- Infographics and risk factors associated with seroprevalence of SARS-CoV-2 antibodies in HCWs-As a component of our COVID research we conducted a seroepidemiology study to measure exposure to SARS-CoV-2 at Addenbrookes hospital.…
- Genomics study identifies routes of transmission of coronavirus in care homes-
- Department of Medicine Scientists launch a pre-emptive strike on deadly post-transplant infection-Dr Ian Groves The Wills/Sinclair group have just published on a potential new treatment to protect immunosuppressed patients from human…
- Lab-grown ‘mini-bile ducts’ used to repair human livers in regenerative medicine first-
- Cambridge Festival trailer – Dr Giles Yeo-
- Study highlights risk of new SARS-CoV-2 mutations emerging during chronic infection-
- SAFETY SCREENS How COVID-19 testing is helping keep Cambridge students – and the wider local population – safe-
- Pfizer BioNTech vaccine likely to be effective against B1.1.7 strain of SARS-CoV-2-
- Likelihood of severe and ‘long’ COVID may be established very early on following infection-